- Home
- FVCB vs PRQR Comparison
FVCB vs PRQR Comparison
Compare FVCB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVCB
- PRQR
- Stock Information
- Founded
- FVCB 2007
- PRQR 2012
- Country
- FVCB United States
- PRQR Netherlands
- Employees
- FVCB N/A
- PRQR N/A
- Industry
- FVCB Major Banks
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- FVCB Finance
- PRQR Health Care
- Exchange
- FVCB Nasdaq
- PRQR Nasdaq
- Market Cap
- FVCB 240.3M
- PRQR 232.8M
- IPO Year
- FVCB N/A
- PRQR 2014
- Fundamental
- Price
- FVCB $13.30
- PRQR $2.06
- Analyst Decision
- FVCB Buy
- PRQR Strong Buy
- Analyst Count
- FVCB 1
- PRQR 8
- Target Price
- FVCB $16.00
- PRQR $8.88
- AVG Volume (30 Days)
- FVCB 37.0K
- PRQR 368.1K
- Earning Date
- FVCB 10-21-2025
- PRQR 11-06-2025
- Dividend Yield
- FVCB 1.78%
- PRQR N/A
- EPS Growth
- FVCB 359.39
- PRQR N/A
- EPS
- FVCB 1.11
- PRQR N/A
- Revenue
- FVCB $62,780,000.00
- PRQR $20,129,184.00
- Revenue This Year
- FVCB $10.08
- PRQR N/A
- Revenue Next Year
- FVCB $7.22
- PRQR N/A
- P/E Ratio
- FVCB $12.17
- PRQR N/A
- Revenue Growth
- FVCB 40.73
- PRQR 8.65
- 52 Week Low
- FVCB $9.49
- PRQR $1.07
- 52 Week High
- FVCB $14.50
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- FVCB 51.28
- PRQR 42.63
- Support Level
- FVCB $13.20
- PRQR $1.91
- Resistance Level
- FVCB $13.60
- PRQR $2.50
- Average True Range (ATR)
- FVCB 0.29
- PRQR 0.16
- MACD
- FVCB -0.03
- PRQR -0.04
- Stochastic Oscillator
- FVCB 34.47
- PRQR 25.42
About FVCB FVCBankcorp Inc.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.